{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T18:00:31Z","timestamp":1788976831354,"version":"build-2803163510"},"reference-count":121,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T00:00:00Z","timestamp":1747699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T00:00:00Z","timestamp":1747699200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1007\/s00702-025-02930-2","type":"journal-article","created":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T13:16:00Z","timestamp":1747746960000},"page":"921-941","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Fluid biomarkers in atypical Parkinsonism: current state and future perspectives"],"prefix":"10.1007","volume":"132","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3006-8711","authenticated-orcid":false,"given":"Anastasia","family":"Bougea","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2216-3973","authenticated-orcid":false,"given":"Carlo","family":"Colosimo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristian","family":"Falup-Pecurariu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Palermo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yildiz","family":"Degirmenci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,20]]},"reference":[{"issue":"1","key":"2930_CR1","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1002\/mds.23341","volume":"26","author":"MB Aerts","year":"2011","unstructured":"Aerts MB, Esselink RA, Bloem BR, Verbeek MM (2011) Cerebrospinal fluid tau and phosphorylated tau protein are elevated in corticobasal syndrome. Mov Disord 26(1):169\u2013173. https:\/\/doi.org\/10.1002\/mds.23341","journal-title":"Mov Disord"},{"issue":"2","key":"2930_CR2","doi-asserted-by":"publisher","first-page":"430.e431","DOI":"10.1016\/j.neurobiolaging.2010.12.001","volume":"33","author":"MB Aerts","year":"2012","unstructured":"Aerts MB, Esselink RA, Abdo WF, Bloem BR, Verbeek MM (2012) CSF alpha-synuclein does not differentiate between parkinsonian disorders. Neurobiol Aging 33(2):430.e431-433. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2010.12.001","journal-title":"Neurobiol Aging"},{"issue":"6","key":"2930_CR3","doi-asserted-by":"publisher","first-page":"e867","DOI":"10.1212\/cpj.0000000000001116","volume":"11","author":"E Angelopoulou","year":"2021","unstructured":"Angelopoulou E, Bougea A, Papadopoulos A, Papagiannakis N, Koros C, Simitsi AM, Georgakis MK, Stefanis L (2021) CSF and circulating NfL as biomarkers for the discrimination of Parkinson disease from atypical parkinsonian syndromes: meta-analysis. Neurol Clin Pract 11(6):e867\u2013e875. https:\/\/doi.org\/10.1212\/cpj.0000000000001116","journal-title":"Neurol Clin Pract"},{"issue":"5","key":"2930_CR4","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1212\/WNL.0b013e31827f0fd1","volume":"80","author":"MJ Armstrong","year":"2013","unstructured":"Armstrong MJ, Litvan I, Lang AE, Bak TH, Bhatia KP, Borroni B, Boxer AL, Dickson DW, Grossman M, Hallett M, Josephs KA, Kertesz A, Lee SE, Miller BL, Reich SG, Riley DE, Tolosa E, Tr\u00f6ster AI, Vidailhet M, Weiner WJ (2013) Criteria for the diagnosis of corticobasal degeneration. Neurology 80(5):496\u2013503. https:\/\/doi.org\/10.1212\/WNL.0b013e31827f0fd1","journal-title":"Neurology"},{"issue":"1","key":"2930_CR5","doi-asserted-by":"publisher","first-page":"5411","DOI":"10.1038\/s41598-017-03887-3","volume":"7","author":"X Bai","year":"2017","unstructured":"Bai X, Tang Y, Yu M, Wu L, Liu F, Ni J, Wang Z, Wang J, Fei J, Wang W, Huang F, Wang J (2017) Downregulation of blood serum microRNA 29 family in patients with Parkinson\u2019s disease. Sci Rep 7(1):5411. https:\/\/doi.org\/10.1038\/s41598-017-03887-3","journal-title":"Sci Rep"},{"issue":"1","key":"2930_CR6","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s13195-022-01093-6","volume":"14","author":"S Baiardi","year":"2022","unstructured":"Baiardi S, Quadalti C, Mammana A, Dellavalle S, Zenesini C, Sambati L, Pantieri R, Polischi B, Romano L, Suffritti M, Bentivenga GM, Randi V, Stanzani-Maserati M, Capellari S, Parchi P (2022) Diagnostic value of plasma p-tau181, NfL, and GFAP in a clinical setting cohort of prevalent neurodegenerative dementias. Alzheimer\u2019s Res Ther 14(1):153. https:\/\/doi.org\/10.1186\/s13195-022-01093-6","journal-title":"Alzheimer's Res Ther"},{"key":"2930_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci14010019","author":"CR Balistreri","year":"2023","unstructured":"Balistreri CR, Monastero R (2023) Neuroinflammation and neurodegenerative diseases: how much do we still not know? Brain Sci. https:\/\/doi.org\/10.3390\/brainsci14010019","journal-title":"Brain Sci"},{"issue":"1","key":"2930_CR8","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.parkreldis.2011.08.012","volume":"18","author":"S Bech","year":"2012","unstructured":"Bech S, Hjermind LE, Salvesen L, Nielsen JE, Heegaard NH, J\u00f8rgensen HL, Rosengren L, Blennow K, Zetterberg H, Winge K (2012) Amyloid-related biomarkers and axonal damage proteins in parkinsonian syndromes. Parkinsonism Relat Disord 18(1):69\u201372. https:\/\/doi.org\/10.1016\/j.parkreldis.2011.08.012","journal-title":"Parkinsonism Relat Disord"},{"issue":"2","key":"2930_CR9","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/s12035-012-8330-5","volume":"47","author":"K Beyer","year":"2013","unstructured":"Beyer K, Ariza A (2013) \u03b1-Synuclein posttranslational modification and alternative splicing as a trigger for neurodegeneration. Mol Neurobiol 47(2):509\u2013524. https:\/\/doi.org\/10.1007\/s12035-012-8330-5","journal-title":"Mol Neurobiol"},{"issue":"3","key":"2930_CR10","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1067\/mcp.2001.113989","volume":"69","author":"Biomarkers","year":"2001","unstructured":"Biomarkers (2001) Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 69(3):89\u201395. https:\/\/doi.org\/10.1067\/mcp.2001.113989","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"2930_CR11","doi-asserted-by":"publisher","first-page":"483","DOI":"10.3390\/medicina58040483","volume":"58","author":"A Bougea","year":"2022","unstructured":"Bougea A (2022) MicroRNA as candidate biomarkers in atypical Parkinsonian syndromes: systematic literature review. Medicina (Kaunas, Lithuania) 58(4):483. https:\/\/doi.org\/10.3390\/medicina58040483","journal-title":"Medicina (Kaunas, Lithuania)"},{"issue":"3","key":"2930_CR12","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s00702-019-02137-2","volume":"127","author":"A Bougea","year":"2020","unstructured":"Bougea A, Stefanis L, Emmanouilidou E, Vekrelis K, Kapaki E (2020) High discriminatory ability of peripheral and CFSF biomarkers in Lewy body diseases. J Neural Trans. 127(3):311\u2013322. https:\/\/doi.org\/10.1007\/s00702-019-02137-2","journal-title":"J Neural Trans."},{"issue":"2","key":"2930_CR13","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.neulet.2008.06.040","volume":"441","author":"B Brodacki","year":"2008","unstructured":"Brodacki B, Staszewski J, Toczy\u0142owska B, Koz\u0142owska E, Drela N, Chalimoniuk M, Stepien A (2008) Serum interleukin (IL-2, IL-10, IL-6, IL-4), TNFalpha, and INFgamma concentrations are elevated in patients with atypical and idiopathic parkinsonism. Neurosci Lett 441(2):158\u2013162. https:\/\/doi.org\/10.1016\/j.neulet.2008.06.040","journal-title":"Neurosci Lett"},{"key":"2930_CR14","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/413098","volume":"2015","author":"AM Brouillette","year":"2015","unstructured":"Brouillette AM, \u00d6z G, Gomez CM (2015) Cerebrospinal fluid biomarkers in spinocerebellar ataxia: a pilot study. Dis Markers 2015:413098. https:\/\/doi.org\/10.1155\/2015\/413098","journal-title":"Dis Markers"},{"issue":"1","key":"2930_CR15","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s13024-017-0187-7","volume":"12","author":"T Brudek","year":"2017","unstructured":"Brudek T, Winge K, Folke J, Christensen S, Fog K, Pakkenberg B, Pedersen L (2017) Autoimmune antibody decline in Parkinson\u2019s disease and multiple system atrophy; a step towards immunotherapeutic strategies. Mol Neurodegener 12(1):44. https:\/\/doi.org\/10.1186\/s13024-017-0187-7","journal-title":"Mol Neurodegener"},{"issue":"6","key":"2930_CR16","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1038\/s41591-024-02937-4","volume":"30","author":"M Chatterjee","year":"2024","unstructured":"Chatterjee M, \u00d6zdemir S, Fritz C, M\u00f6bius W, Kleineidam L, Mandelkow E, Biernat J, Do\u011fdu C, Peters O, Cosma NC, Wang X, Schneider LS, Priller J, Spruth E, K\u00fchn AA, Krause P, Klockgether T, Vogt IR, Kimmich O, Spottke A, Hoffmann DC, Fliessbach K, Miklitz C, McCormick C, Weydt P, Falkenburger B, Brandt M, Guenther R, Dinter E, Wiltfang J, Hansen N, B\u00e4hr M, Zerr I, Fl\u00f6el A, Nestor PJ, D\u00fczel E, Glanz W, Incesoy E, B\u00fcrger K, Janowitz D, Perneczky R, Rauchmann BS, Hopfner F, Wagemann O, Levin J, Teipel S, Kilimann I, Goerss D, Prudlo J, Gasser T, Brockmann K, Mengel D, Zimmermann M, Synofzik M, Wilke C, Selma-Gonz\u00e1lez J, Turon-Sans J, Santos-Santos MA, Alcolea D, Rubio-Guerra S, Fortea J, Carbayo \u00c1, Lle\u00f3 A, Rojas-Garc\u00eda R, Ill\u00e1n-Gala I, Wagner M, Frommann I, Roeske S, Bertram L, Heneka MT, Brosseron F, Ramirez A, Schmid M, Beschorner R, Halle A, Herms J, Neumann M, Barth\u00e9lemy NR, Bateman RJ, Rizzu P, Heutink P, Dols-Icardo O, H\u00f6glinger G, Hermann A, Schneider A (2024) Plasma extracellular vesicle tau and TDP-43 as diagnostic biomarkers in FTD and ALS. Nat Med 30(6):1771\u20131783. https:\/\/doi.org\/10.1038\/s41591-024-02937-4","journal-title":"Nat Med"},{"issue":"12","key":"2930_CR17","doi-asserted-by":"publisher","first-page":"4398","DOI":"10.1093\/brain\/awac253","volume":"145","author":"V Chelban","year":"2022","unstructured":"Chelban V, Nikram E, Perez-Soriano A, Wilke C, Foubert-Samier A, Vijiaratnam N, Guo T, Jabbari E, Olufodun S, Gonzalez M, Senkevich K, Laurens B, P\u00e9ran P, Rascol O, Le Traon AP, Todd EG, Costantini AA, Alikhwan S, Tariq A, Ng BL, Mu\u00f1oz E, Painous C, Compta Y, Junque C, Segura B, Zhelcheska K, Wellington H, Sch\u00f6ls L, Jaunmuktane Z, Kobylecki C, Church A, Hu MTM, Rowe JB, Leigh PN, Massey L, Burn DJ, Pavese N, Foltynie T, Pchelina S, Wood N, Heslegrave AJ, Zetterberg H, Bocchetta M, Rohrer JD, Marti MJ, Synofzik M, Morris HR, Meissner WG, Houlden H (2022) Neurofilament light levels predict clinical progression and death in multiple system atrophy. Brain 145(12):4398\u20134408. https:\/\/doi.org\/10.1093\/brain\/awac253","journal-title":"Brain"},{"key":"2930_CR18","doi-asserted-by":"publisher","first-page":"119975","DOI":"10.1016\/j.cca.2024.119975","volume":"565","author":"Y Chen","year":"2024","unstructured":"Chen Y, Huang J, Li Y, Chen X, Ye Q (2024) Diagnostic value of six plasma biomarkers in progressive supranuclear palsy, multiple system atrophy, and Parkinson\u2019s disease. Clin Chim Acta Int J Clin Chem. 565:119975. https:\/\/doi.org\/10.1016\/j.cca.2024.119975","journal-title":"Clin Chim Acta Int J Clin Chem."},{"issue":"6","key":"2930_CR19","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1136\/jnnp-2021-327788","volume":"93","author":"L Chouliaras","year":"2022","unstructured":"Chouliaras L, Thomas A, Malpetti M, Donaghy P, Kane J, Mak E, Savulich G, Prats-Sedano MA, Heslegrave AJ, Zetterberg H, Su L, Rowe JB, O\u2019Brien JT (2022) Differential levels of plasma biomarkers of neurodegeneration in Lewy body dementia, Alzheimer\u2019s disease, frontotemporal dementia and progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 93(6):651\u2013658. https:\/\/doi.org\/10.1136\/jnnp-2021-327788","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"12","key":"2930_CR20","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1097\/nen.0000000000000018","volume":"72","author":"M Colom-Cadena","year":"2013","unstructured":"Colom-Cadena M, Gelpi E, Charif S, Belbin O, Blesa R, Mart\u00ed MJ, Clarim\u00f3n J, Lle\u00f3 A (2013) Confluence of \u03b1-synuclein, tau, and \u03b2-amyloid pathologies in dementia with Lewy bodies. J Neuropathol Exp Neurol 72(12):1203\u20131212. https:\/\/doi.org\/10.1097\/nen.0000000000000018","journal-title":"J Neuropathol Exp Neurol"},{"key":"2930_CR21","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.parkreldis.2019.05.040","volume":"65","author":"Y Compta","year":"2019","unstructured":"Compta Y, Dias SP, Giraldo DM, P\u00e9rez-Soriano A, Mu\u00f1oz E, Saura J, Fern\u00e1ndez M, Bravo P, C\u00e1mara A, Pulido-Salgado M, Painous C, R\u00edos J, Mart\u00ed MJ (2019) Cerebrospinal fluid cytokines in multiple system atrophy: a cross-sectional Catalan MSA registry study. Parkinsonism Relat Disord 65:3\u201312. https:\/\/doi.org\/10.1016\/j.parkreldis.2019.05.040","journal-title":"Parkinsonism Relat Disord"},{"issue":"8","key":"2930_CR22","doi-asserted-by":"publisher","first-page":"2703","DOI":"10.1007\/s00415-020-09781-9","volume":"268","author":"S Cong","year":"2021","unstructured":"Cong S, Xiang C, Wang H, Cong S (2021) Diagnostic utility of fluid biomarkers in multiple system atrophy: a systematic review and meta-analysis. J Neurol 268(8):2703\u20132712. https:\/\/doi.org\/10.1007\/s00415-020-09781-9","journal-title":"J Neurol"},{"issue":"2","key":"2930_CR23","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.parkreldis.2009.07.007","volume":"16","author":"R Constantinescu","year":"2010","unstructured":"Constantinescu R, Rosengren L, Johnels B, Zetterberg H, Holmberg B (2010) Consecutive analyses of cerebrospinal fluid axonal and glial markers in Parkinson\u2019s disease and atypical Parkinsonian disorders. Parkinsonism Relat Disord 16(2):142\u2013145. https:\/\/doi.org\/10.1016\/j.parkreldis.2009.07.007","journal-title":"Parkinsonism Relat Disord"},{"key":"2930_CR24","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.jns.2017.09.039","volume":"382","author":"VC Constantinides","year":"2017","unstructured":"Constantinides VC, Paraskevas GP, Emmanouilidou E, Petropoulou O, Bougea A, Vekrellis K, Evdokimidis I, Stamboulis E, Kapaki E (2017) CSF biomarkers \u03b2-amyloid, tau proteins and a-synuclein in the differential diagnosis of Parkinson-plus syndromes. J Neurol Sci 382:91\u201395. https:\/\/doi.org\/10.1016\/j.jns.2017.09.039","journal-title":"J Neurol Sci"},{"issue":"1","key":"2930_CR25","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3390\/brainsci11010119","volume":"11","author":"VC Constantinides","year":"2021","unstructured":"Constantinides VC, Majbour NK, Paraskevas GP, Abdi I, Safieh-Garabedian B, Stefanis L, El-Agnaf OM, Kapaki E (2021) Cerebrospinal fluid \u03b1-synuclein species in cognitive and movements disorders. Brain Sci. 11(1):119. https:\/\/doi.org\/10.3390\/brainsci11010119","journal-title":"Brain Sci."},{"issue":"4","key":"2930_CR26","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1007\/s00401-022-02480-x","volume":"144","author":"DG Coughlin","year":"2022","unstructured":"Coughlin DG, Goodwill VS, Standke HG, Kim Y, Coley N, Pizzo DP, Galasko D, Kraus A, Hiniker A (2022) Selective tau seeding assays and isoform-specific antibodies define neuroanatomic distribution of progressive supranuclear palsy pathology arising in Alzheimer\u2019s disease. Acta Neuropathol 144(4):789\u2013792. https:\/\/doi.org\/10.1007\/s00401-022-02480-x","journal-title":"Acta Neuropathol"},{"issue":"11","key":"2930_CR27","doi-asserted-by":"publisher","first-page":"2510","DOI":"10.3390\/biomedicines12112510","volume":"12","author":"CM Cristiani","year":"2024","unstructured":"Cristiani CM, Scaramuzzino L, Parrotta EI, Cuda G, Quattrone A, Quattrone A (2024) Erythrocytic \u03b1-synuclein in Parkinson\u2019s disease and progressive supranuclear palsy-a pilot study. Biomedicines. 12(11):2510. https:\/\/doi.org\/10.3390\/biomedicines12112510","journal-title":"Biomedicines."},{"key":"2930_CR28","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.parkreldis.2018.06.018","volume":"56","author":"L Donker Kaat","year":"2018","unstructured":"Donker Kaat L, Meeter LH, Chiu WZ, Melhem S, Boon AJW, Blennow K, Zetterberg H, van Swieten JC (2018) Serum neurofilament light chain in progressive supranuclear palsy. Parkinsonism Relat Disord 56:98\u2013101. https:\/\/doi.org\/10.1016\/j.parkreldis.2018.06.018","journal-title":"Parkinsonism Relat Disord"},{"issue":"3","key":"2930_CR29","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s00401-021-02324-0","volume":"142","author":"S Dutta","year":"2021","unstructured":"Dutta S, Hornung S, Kruayatidee A, Maina KN, Del Rosario I, Paul KC, Wong DY, Duarte Folle A, Markovic D, Palma JA, Serrano GE, Adler CH, Perlman SL, Poon WW, Kang UJ, Alcalay RN, Sklerov M, Gylys KH, Kaufmann H, Fogel BL, Bronstein JM, Ritz B, Bitan G (2021) \u03b1-Synuclein in blood exosomes immunoprecipitated using neuronal and oligodendroglial markers distinguishes Parkinson\u2019s disease from multiple system atrophy. Acta Neuropathol 142(3):495\u2013511. https:\/\/doi.org\/10.1007\/s00401-021-02324-0","journal-title":"Acta Neuropathol"},{"key":"2930_CR30","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.parkreldis.2021.05.001","volume":"87","author":"J Folke","year":"2021","unstructured":"Folke J, Rydbirk R, L\u00f8kkegaard A, Hejl AM, Winge K, Starhof C, Salvesen L, Pedersen L, Aznar S, Pakkenberg B, Brudek T (2021) Cerebrospinal fluid and plasma distribution of anti-\u03b1-synuclein IgMs and IgGs in multiple system atrophy and Parkinson\u2019s disease. Parkinsonism Relat Disord 87:98\u2013104. https:\/\/doi.org\/10.1016\/j.parkreldis.2021.05.001","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"2930_CR31","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.nbd.2011.08.003","volume":"45","author":"PG Foulds","year":"2012","unstructured":"Foulds PG, Yokota O, Thurston A, Davidson Y, Ahmed Z, Holton J, Thompson JC, Akiyama H, Arai T, Hasegawa M, Gerhard A, Allsop D, Mann DM (2012) Post mortem cerebrospinal fluid alpha-synuclein levels are raised in multiple system atrophy and distinguish this from the other alpha-synucleinopathies, Parkinson\u2019s disease and Dementia with Lewy bodies. Neurobiol Dis 45(1):188\u2013195. https:\/\/doi.org\/10.1016\/j.nbd.2011.08.003","journal-title":"Neurobiol Dis"},{"key":"2930_CR32","doi-asserted-by":"publisher","first-page":"1210220","DOI":"10.3389\/fneur.2023.1210220","volume":"14","author":"M Goolla","year":"2023","unstructured":"Goolla M, Cheshire WP, Ross OA, Kondru N (2023) Diagnosing multiple system atrophy: current clinical guidance and emerging molecular biomarkers. Front Neurol 14:1210220. https:\/\/doi.org\/10.3389\/fneur.2023.1210220","journal-title":"Front Neurol"},{"issue":"11","key":"2930_CR33","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1001\/archneurol.2012.1654","volume":"69","author":"S Hall","year":"2012","unstructured":"Hall S, \u00d6hrfelt A, Constantinescu R, Andreasson U, Surova Y, Bostrom F, Nilsson C, H\u00e5kan W, Decraemer H, N\u00e5gga K, Minthon L, Londos E, Vanmechelen E, Holmberg B, Zetterberg H, Blennow K, Hansson O (2012) Accuracy of a panel of 5 cerebrospinal fluid biomarkers in the differential diagnosis of patients with dementia and\/or parkinsonian disorders. Arch Neurol 69(11):1445\u20131452. https:\/\/doi.org\/10.1001\/archneurol.2012.1654","journal-title":"Arch Neurol"},{"issue":"1","key":"2930_CR34","doi-asserted-by":"publisher","first-page":"13276","DOI":"10.1038\/s41598-018-31517-z","volume":"8","author":"S Hall","year":"2018","unstructured":"Hall S, Janelidze S, Surova Y, Widner H, Zetterberg H, Hansson O (2018) Cerebrospinal fluid concentrations of inflammatory markers in Parkinson\u2019s disease and atypical parkinsonian disorders. Sci Rep 8(1):13276. https:\/\/doi.org\/10.1038\/s41598-018-31517-z","journal-title":"Sci Rep"},{"issue":"6","key":"2930_CR35","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1002\/mds.26987","volume":"32","author":"GU H\u00f6glinger","year":"2017","unstructured":"H\u00f6glinger GU, Respondek G, Stamelou M, Kurz C, Josephs KA, Lang AE, Mollenhauer B, M\u00fcller U, Nilsson C, Whitwell JL, Arzberger T, Englund E, Gelpi E, Giese A, Irwin DJ, Meissner WG, Pantelyat A, Rajput A, van Swieten JC, Troakes C, Antonini A, Bhatia KP, Bordelon Y, Compta Y, Corvol JC, Colosimo C, Dickson DW, Dodel R, Ferguson L, Grossman M, Kassubek J, Krismer F, Levin J, Lorenzl S, Morris HR, Nestor P, Oertel WH, Poewe W, Rabinovici G, Rowe JB, Schellenberg GD, Seppi K, van Eimeren T, Wenning GK, Boxer AL, Golbe LI, Litvan I (2017) Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria. Mov Disord 32(6):853\u2013864. https:\/\/doi.org\/10.1002\/mds.26987","journal-title":"Mov Disord"},{"issue":"1","key":"2930_CR36","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1002\/mds.870130116","volume":"13","author":"B Holmberg","year":"1998","unstructured":"Holmberg B, Rosengren L, Karlsson JE, Johnels B (1998) Increased cerebrospinal fluid levels of neurofilament protein in progressive supranuclear palsy and multiple-system atrophy compared with Parkinson\u2019s disease. Mov Disord 13(1):70\u201377. https:\/\/doi.org\/10.1002\/mds.870130116","journal-title":"Mov Disord"},{"issue":"12","key":"2930_CR37","doi-asserted-by":"publisher","first-page":"2547","DOI":"10.1038\/s41591-022-02075-9","volume":"28","author":"K Horie","year":"2022","unstructured":"Horie K, Barth\u00e9lemy NR, Spina S, VandeVrede L, He Y, Paterson RW, Wright BA, Day GS, Davis AA, Karch CM, Seeley WW, Perrin RJ, Koppisetti RK, Shaikh F, Lago AL, Heuer HW, Ghoshal N, Gabelle A, Miller BL, Boxer AL, Bateman RJ, Sato C (2022) CSF tau microtubule-binding region identifies pathological changes in primary tauopathies. Nat Med 28(12):2547\u20132554. https:\/\/doi.org\/10.1038\/s41591-022-02075-9","journal-title":"Nat Med"},{"issue":"4","key":"2930_CR38","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1002\/mds.29339","volume":"38","author":"SY Huang","year":"2023","unstructured":"Huang SY, Chen SF, Cui M, Zhao M, Shen XN, Guo Y, Zhang YR, Zhang W, Wang HF, Huang YY, Cheng W, Zuo CT, Dong Q, Yu JT (2023) Plasma biomarkers and positron emission tomography tau pathology in progressive supranuclear palsy. Mov Disord 38(4):676\u2013682. https:\/\/doi.org\/10.1002\/mds.29339","journal-title":"Mov Disord"},{"issue":"6","key":"2930_CR39","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1002\/mds.28011","volume":"35","author":"M Jecmenica Lukic","year":"2020","unstructured":"Jecmenica Lukic M, Kurz C, Respondek G, Grau-Rivera O, Compta Y, Gelpi E, Troakes C, van Swieten JC, Giese A, Roeber S, Arzberger T, H\u00f6glinger G (2020) Copathology in progressive supranuclear palsy: does it matter? Mov Disord 35(6):984\u2013993. https:\/\/doi.org\/10.1002\/mds.28011","journal-title":"Mov Disord"},{"issue":"7","key":"2930_CR40","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1136\/jnnp-2019-322588","volume":"91","author":"C Jiang","year":"2020","unstructured":"Jiang C, Hopfner F, Katsikoudi A, Hein R, Catli C, Evetts S, Huang Y, Wang H, Ryder JW, Kuhlenbaeumer G, Deuschl G, Padovani A, Berg D, Borroni B, Hu MT, Davis JJ, Tofaris GK (2020) Serum neuronal exosomes predict and differentiate Parkinson\u2019s disease from atypical parkinsonism. J Neurol Neurosurg Psychiatry 91(7):720\u2013729. https:\/\/doi.org\/10.1136\/jnnp-2019-322588","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2930_CR03","doi-asserted-by":"crossref","unstructured":"Jiang X, Xiao L, Jiang X, Li G, Lu Z. Screening of Parkinson's Differential MicroRNA Based on GEO Database and Its Clinical Verification. Biomed Res Int. 2021;2021:8171236.","DOI":"10.1155\/2021\/8171236"},{"issue":"7","key":"2930_CR41","doi-asserted-by":"publisher","first-page":"951","DOI":"10.3390\/biology11070951","volume":"11","author":"Y Kanatani","year":"2022","unstructured":"Kanatani Y, Sato Y, Nemoto S, Ichikawa M, Onodera O (2022) Improving the accuracy of diagnosis for multiple-system atrophy using deep learning-based method. Biology 11(7):951. https:\/\/doi.org\/10.3390\/biology11070951","journal-title":"Biology"},{"issue":"4","key":"2930_CR42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0062354","volume":"8","author":"E Kaufman","year":"2013","unstructured":"Kaufman E, Hall S, Surova Y, Widner H, Hansson O, Lindqvist D (2013) Proinflammatory cytokines are elevated in serum of patients with multiple system atrophy. PLoS ONE 8(4):e62354. https:\/\/doi.org\/10.1371\/journal.pone.0062354","journal-title":"PLoS ONE"},{"key":"2930_CR43","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.parkreldis.2019.03.020","volume":"64","author":"R Kim","year":"2019","unstructured":"Kim R, Kim HJ, Kim A, Jang M, Kim A, Kim Y, Yoo D, Im JH, Choi JH, Jeon B (2019) Does peripheral inflammation contribute to multiple system atrophy? Parkinsonism Relat Disord 64:340\u2013341. https:\/\/doi.org\/10.1016\/j.parkreldis.2019.03.020","journal-title":"Parkinsonism Relat Disord"},{"key":"2930_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2020.610798","volume":"11","author":"M Krassowski","year":"2020","unstructured":"Krassowski M, Das V, Sahu SK, Misra BB (2020) State of the field in multi-omics research: from computational needs to data mining and sharing. Front Genet 11:610798. https:\/\/doi.org\/10.3389\/fgene.2020.610798","journal-title":"Front Genet"},{"key":"2930_CR45","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.nbd.2015.05.004","volume":"80","author":"B Laurens","year":"2015","unstructured":"Laurens B, Constantinescu R, Freeman R, Gerhard A, Jellinger K, Jeromin A, Krismer F, Mollenhauer B, Schlossmacher MG, Shaw LM, Verbeek MM, Wenning GK, Winge K, Zhang J, Meissner WG (2015) Fluid biomarkers in multiple system atrophy: a review of the MSA biomarker initiative. Neurobiol Dis 80:29\u201341. https:\/\/doi.org\/10.1016\/j.nbd.2015.05.004","journal-title":"Neurobiol Dis"},{"issue":"10","key":"2930_CR46","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1007\/s00702-005-0427-9","volume":"113","author":"PH Lee","year":"2006","unstructured":"Lee PH, Lee G, Park HJ, Bang OY, Joo IS, Huh K (2006) The plasma alpha-synuclein levels in patients with Parkinson\u2019s disease and multiple system atrophy. J Neural Trans. 113(10):1435\u20131439. https:\/\/doi.org\/10.1007\/s00702-005-0427-9","journal-title":"J Neural Trans."},{"issue":"8","key":"2930_CR47","first-page":"10470","volume":"12","author":"X Li","year":"2019","unstructured":"Li X, Yang W, Li A, Li X, Chen Z, Wang C, Yu S (2019) Levels of oligomeric alpha-synuclein in red blood cells are elevated in patients with Parkinson\u2019s disease and affected by brain alpha-synuclein expression. Int J Clin Exp Med 12(8):10470\u201310477","journal-title":"Int J Clin Exp Med"},{"key":"2930_CR48","doi-asserted-by":"publisher","first-page":"8740419","DOI":"10.1155\/2020\/8740419","volume":"2020","author":"XY Li","year":"2020","unstructured":"Li XY, Yang W, Li XR, Li W, Song Q, Sun L, Lin F, Chen Z, Wang C, Yu S (2020) Phosphorylated alpha-synuclein in red blood cells as a potential diagnostic biomarker for multiple system atrophy: a pilot study. Parkinson\u2019s Disease 2020:8740419. https:\/\/doi.org\/10.1155\/2020\/8740419","journal-title":"Parkinson's Disease"},{"key":"2930_CR49","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2022.805953","volume":"16","author":"Q Li","year":"2022","unstructured":"Li Q, Li Z, Han X, Shen X, Wang F, Bai L, Li Z, Zhang R, Wang Y, Zhu X (2022) A panel of plasma biomarkers for differential diagnosis of parkinsonian syndromes. Front Neurosci 16:805953. https:\/\/doi.org\/10.3389\/fnins.2022.805953","journal-title":"Front Neurosci"},{"key":"2930_CR50","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.parkreldis.2018.09.012","volume":"60","author":"G Liu","year":"2019","unstructured":"Liu G, Tian C, Gao L, Cao Z, Feng T (2019) Alpha-synuclein in erythrocyte membrane of patients with multiple system atrophy: a pilot study. Parkinsonism Relat Disord 60:105\u2013110. https:\/\/doi.org\/10.1016\/j.parkreldis.2018.09.012","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"2930_CR51","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s13024-017-0226-4","volume":"12","author":"F Llorens","year":"2017","unstructured":"Llorens F, Th\u00fcne K, Tahir W, Kanata E, Diaz-Lucena D, Xanthopoulos K, Kovatsi E, Pleschka C, Garcia-Esparcia P, Schmitz M, Ozbay D, Correia S, Correia \u00c2, Milosevic I, Andr\u00e9oletti O, Fern\u00e1ndez-Borges N, Vorberg IM, Glatzel M, Sklaviadis T, Torres JM, Krasemann S, S\u00e1nchez-Valle R, Ferrer I, Zerr I (2017) YKL-40 in the brain and cerebrospinal fluid of neurodegenerative dementias. Mol Neurodegener 12(1):83. https:\/\/doi.org\/10.1186\/s13024-017-0226-4","journal-title":"Mol Neurodegener"},{"issue":"5","key":"2930_CR52","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1007\/s12264-017-0183-5","volume":"33","author":"S Lotankar","year":"2017","unstructured":"Lotankar S, Prabhavalkar KS, Bhatt LK (2017) Biomarkers for Parkinson\u2019s disease: recent advancement. Neurosci Bull 33(5):585\u2013597. https:\/\/doi.org\/10.1007\/s12264-017-0183-5","journal-title":"Neurosci Bull"},{"issue":"12","key":"2930_CR53","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1016\/s1474-4422(24)00395-8","volume":"23","author":"Y Ma","year":"2024","unstructured":"Ma Y, Farris CM, Weber S, Schade S, Nguyen H, P\u00e9rez-Soriano A, Giraldo DM, Fern\u00e1ndez M, Soto M, C\u00e1mara A, Painous C, Mu\u00f1oz E, Valldeoriola F, Mart\u00ed MJ, Clarimon J, Kallunki P, Ma TC, Alcalay RN, Gomes BF, Blennow K, Zetterberg H, Constantinescu J, Mengel D, Kadam V, Parchi P, Brockmann K, Tropea TF, Siderowf A, Synofzik M, Kang UJ, Compta Y, Svenningsson P, Mollenhauer B, Concha-Marambio L (2024) Sensitivity and specificity of a seed amplification assay for diagnosis of multiple system atrophy: a multicentre cohort study. Lancet Neurol 23(12):1225\u20131237. https:\/\/doi.org\/10.1016\/s1474-4422(24)00395-8","journal-title":"Lancet Neurol"},{"issue":"1","key":"2930_CR54","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3233\/jad-2011-110221","volume":"26","author":"W Maetzler","year":"2011","unstructured":"Maetzler W, Berg D, Synofzik M, Brockmann K, Godau J, Melms A, Gasser T, H\u00f6rnig S, Langkamp M (2011) Autoantibodies against amyloid and glial-derived antigens are increased in serum and cerebrospinal fluid of Lewy body-associated dementias. J Alzheimer\u2019s Dis 26(1):171\u2013179. https:\/\/doi.org\/10.3233\/jad-2011-110221","journal-title":"J Alzheimer\u2019s Dis"},{"issue":"1","key":"2930_CR55","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/s41531-022-00357-0","volume":"8","author":"P Magalh\u00e3es","year":"2022","unstructured":"Magalh\u00e3es P, Lashuel HA (2022) Opportunities and challenges of alpha-synuclein as a potential biomarker for Parkinson\u2019s disease and other synucleinopathies. NPJ Parkinson\u2019s Dis 8(1):93. https:\/\/doi.org\/10.1038\/s41531-022-00357-0","journal-title":"NPJ Parkinson's Dis"},{"issue":"11","key":"2930_CR56","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1136\/jnnp-2014-309562","volume":"86","author":"NK Magdalinou","year":"2015","unstructured":"Magdalinou NK, Paterson RW, Schott JM, Fox NC, Mummery C, Blennow K, Bhatia K, Morris HR, Giunti P, Warner TT, de Silva R, Lees AJ, Zetterberg H (2015) A panel of nine cerebrospinal fluid biomarkers may identify patients with atypical parkinsonian syndromes. J Neurol Neurosurg Psychiatry 86(11):1240\u20131247. https:\/\/doi.org\/10.1136\/jnnp-2014-309562","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2930_CR57","doi-asserted-by":"publisher","DOI":"10.1515\/cclm-2023-1472","author":"A Mammana","year":"2024","unstructured":"Mammana A, Baiardi S, Rossi M, Quadalti C, Ticca A, Magliocchetti F, Bernhardt A, Capellari S, Parchi P (2024) Improving protocols for \u03b1-synuclein seed amplification assays: analysis of preanalytical and analytical variables and identification of candidate parameters for seed quantification. Clin Chem Lab Med. https:\/\/doi.org\/10.1515\/cclm-2023-1472","journal-title":"Clin Chem Lab Med"},{"issue":"10","key":"2930_CR58","doi-asserted-by":"publisher","first-page":"7736","DOI":"10.1007\/s12035-016-0253-0","volume":"54","author":"TM Marques","year":"2017","unstructured":"Marques TM, Kuiperij HB, Bruinsma IB, van Rumund A, Aerts MB, Esselink RAJ, Bloem BR, Verbeek MM (2017) MicroRNAs in cerebrospinal fluid as potential biomarkers for Parkinson\u2019s disease and multiple system atrophy. Mol Neurobiol 54(10):7736\u20137745. https:\/\/doi.org\/10.1007\/s12035-016-0253-0","journal-title":"Mol Neurobiol"},{"issue":"4","key":"2930_CR59","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1212\/con.0000000000000348","volume":"22","author":"NR McFarland","year":"2016","unstructured":"McFarland NR (2016) Diagnostic approach to atypical Parkinsonian syndromes. Continuum. 22(4):1117\u20131142. https:\/\/doi.org\/10.1212\/con.0000000000000348","journal-title":"Continuum."},{"issue":"1","key":"2930_CR60","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1007\/s004150050173","volume":"245","author":"K Mitani","year":"1998","unstructured":"Mitani K, Furiya Y, Uchihara T, Ishii K, Yamanouchi H, Mizusawa H, Mori H (1998) Increased CSF tau protein in corticobasal degeneration. J Neurol 245(1):44\u201346. https:\/\/doi.org\/10.1007\/s004150050173","journal-title":"J Neurol"},{"issue":"6","key":"2930_CR61","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/j.jalz.2014.03.003","volume":"10","author":"JL Molinuevo","year":"2014","unstructured":"Molinuevo JL, Blennow K, Dubois B, Engelborghs S, Lewczuk P, Perret-Liaudet A, Teunissen CE, Parnetti L (2014) The clinical use of cerebrospinal fluid biomarker testing for Alzheimer\u2019s disease diagnosis: a consensus paper from the Alzheimer\u2019s Biomarkers Standardization Initiative. Alzheimer\u2019s Dement 10(6):808\u2013817. https:\/\/doi.org\/10.1016\/j.jalz.2014.03.003","journal-title":"Alzheimer's Dement"},{"issue":"2","key":"2930_CR62","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.expneurol.2008.06.004","volume":"213","author":"B Mollenhauer","year":"2008","unstructured":"Mollenhauer B, Cullen V, Kahn I, Krastins B, Outeiro TF, Pepivani I, Ng J, Schulz-Schaeffer W, Kretzschmar HA, McLean PJ, Trenkwalder C, Sarracino DA, Vonsattel JP, Locascio JJ, El-Agnaf OM, Schlossmacher MG (2008) Direct quantification of CSF alpha-synuclein by ELISA and first cross-sectional study in patients with neurodegeneration. Exp Neurol 213(2):315\u2013325. https:\/\/doi.org\/10.1016\/j.expneurol.2008.06.004","journal-title":"Exp Neurol"},{"issue":"3","key":"2930_CR63","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/s1474-4422(11)70014-x","volume":"10","author":"B Mollenhauer","year":"2011","unstructured":"Mollenhauer B, Locascio JJ, Schulz-Schaeffer W, Sixel-Doring F, Trenkwalder C, Schlossmacher MG (2011) alpha-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study. Lancet Neurol 10(3):230\u2013240. https:\/\/doi.org\/10.1016\/s1474-4422(11)70014-x","journal-title":"Lancet Neurol"},{"issue":"1","key":"2930_CR64","doi-asserted-by":"publisher","first-page":"7803","DOI":"10.1038\/s41598-019-44173-8","volume":"9","author":"E Morenas-Rodr\u00edguez","year":"2019","unstructured":"Morenas-Rodr\u00edguez E, Alcolea D, Su\u00e1rez-Calvet M, Mu\u00f1oz-Llahuna L, Vilaplana E, Sala I, Subirana A, Querol-Vilaseca M, Carmona-Iragui M, Ill\u00e1n-Gala I, Ribosa-Nogu\u00e9 R, Blesa R, Haass C, Fortea J, Lle\u00f3 A (2019) Different pattern of CSF glial markers between dementia with Lewy bodies and Alzheimer\u2019s disease. Sci Rep 9(1):7803. https:\/\/doi.org\/10.1038\/s41598-019-44173-8","journal-title":"Sci Rep"},{"issue":"1\u20132","key":"2930_CR65","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.jns.2005.05.015","volume":"237","author":"M Noguchi","year":"2005","unstructured":"Noguchi M, Yoshita M, Matsumoto Y, Ono K, Iwasa K, Yamada M (2005) Decreased beta-amyloid peptide42 in cerebrospinal fluid of patients with progressive supranuclear palsy and corticobasal degeneration. J Neurol Sci 237(1\u20132):61\u201365. https:\/\/doi.org\/10.1016\/j.jns.2005.05.015","journal-title":"J Neurol Sci"},{"key":"2930_CR66","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2022.12604","author":"W Nonaka","year":"2022","unstructured":"Nonaka W, Takata T, Iwama H, Komatsubara S, Kobara H, Kamada M, Deguchi K, Touge T, Miyamoto O, Nakamura T, Itano T, Masaki T (2022) A cerebrospinal fluid microRNA analysis: progressive supranuclear palsy. Mol Med Rep. https:\/\/doi.org\/10.3892\/mmr.2022.12604","journal-title":"Mol Med Rep"},{"issue":"1","key":"2930_CR67","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s12017-012-8208-8","volume":"15","author":"M Nutu","year":"2013","unstructured":"Nutu M, Bourgeois P, Zetterberg H, Portelius E, Andreasson U, Parent S, Lipari F, Hall S, Constantinescu R, Hansson O, Blennow K (2013) A\u03b21-15\/16 as a potential diagnostic marker in neurodegenerative diseases. NeuroMol Med 15(1):169\u2013179. https:\/\/doi.org\/10.1007\/s12017-012-8208-8","journal-title":"NeuroMol Med"},{"key":"2930_CR68","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.parkreldis.2018.11.021","volume":"61","author":"T Ohmichi","year":"2019","unstructured":"Ohmichi T, Mitsuhashi M, Tatebe H, Kasai T, Ali El-Agnaf OM, Tokuda T (2019) Quantification of brain-derived extracellular vesicles in plasma as a biomarker to diagnose Parkinson\u2019s and related diseases. Parkinsonism Relat Disord 61:82\u201387. https:\/\/doi.org\/10.1016\/j.parkreldis.2018.11.021","journal-title":"Parkinsonism Relat Disord"},{"issue":"6","key":"2930_CR69","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1038\/s41591-023-02358-9","volume":"29","author":"A Okuzumi","year":"2023","unstructured":"Okuzumi A, Hatano T, Matsumoto G, Nojiri S, Ueno SI, Imamichi-Tatano Y, Kimura H, Kakuta S, Kondo A, Fukuhara T, Li Y, Funayama M, Saiki S, Taniguchi D, Tsunemi T, McIntyre D, G\u00e9rardy JJ, Mittelbronn M, Kruger R, Uchiyama Y, Nukina N, Hattori N (2023) Propagative \u03b1-synuclein seeds as serum biomarkers for synucleinopathies. Nat Med 29(6):1448\u20131455. https:\/\/doi.org\/10.1038\/s41591-023-02358-9","journal-title":"Nat Med"},{"key":"2930_CR70","doi-asserted-by":"publisher","first-page":"974799","DOI":"10.3389\/fmolb.2022.974799","volume":"9","author":"E Oldoni","year":"2022","unstructured":"Oldoni E, Saunders G, Bietrix F, Garcia Bermejo ML, Niehues A, Hoen PAC, Nordlund J, Hajduch M, Scherer A, Kivinen K, Pitk\u00e4nen E, M\u00e4kela TP, Gut I, Scollen S, Kozera \u0141, Esteller M, Shi L, Ussi A, Andreu AL, van Gool AJ (2022) Tackling the translational challenges of multi-omics research in the realm of European personalised medicine: a workshop report. Front Mol Biosci 9:974799. https:\/\/doi.org\/10.3389\/fmolb.2022.974799","journal-title":"Front Mol Biosci"},{"key":"2930_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2022.11.018","volume":"106","author":"K Oliveira Hauer","year":"2023","unstructured":"Oliveira Hauer K, Pawlik D, Leuzy A, Janelidze S, Hall S, Hansson O, Smith R (2023) Performance of [(18)F]RO948 PET, MRI and CSF neurofilament light in the differential diagnosis of progressive supranuclear palsy. Parkinsonism Relat Disord 106:105226. https:\/\/doi.org\/10.1016\/j.parkreldis.2022.11.018","journal-title":"Parkinsonism Relat Disord"},{"issue":"13","key":"2930_CR72","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1002\/mds.25589","volume":"28","author":"B Olsson","year":"2013","unstructured":"Olsson B, Constantinescu R, Holmberg B, Andreasen N, Blennow K, Zetterberg H (2013) The glial marker YKL-40 is decreased in synucleinopathies. Mov Disord 28(13):1882\u20131885. https:\/\/doi.org\/10.1002\/mds.25589","journal-title":"Mov Disord"},{"issue":"4\u20136","key":"2930_CR73","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1159\/000500567","volume":"47","author":"GP Paraskevas","year":"2019","unstructured":"Paraskevas GP, Bougea A, Constantinides VC, Bourbouli M, Petropoulou O, Kapaki E (2019) In vivo prevalence of Alzheimer biomarkers in dementia with lewy bodies. Dement Geriatr Cogn Disord 47(4\u20136):289\u2013296. https:\/\/doi.org\/10.1159\/000500567","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"4","key":"2930_CR74","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1007\/s11011-024-01342-7","volume":"39","author":"A Pasqualotto","year":"2024","unstructured":"Pasqualotto A, da Silva V, Pellenz FM, Schuh AFS, Schwartz IVD, Siebert M (2024) Identification of metabolic pathways and key genes associated with atypical parkinsonism using a systems biology approach. Metab Brain Dis 39(4):577\u2013587. https:\/\/doi.org\/10.1007\/s11011-024-01342-7","journal-title":"Metab Brain Dis"},{"issue":"2","key":"2930_CR75","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1093\/brain\/awab431","volume":"145","author":"I Poggiolini","year":"2022","unstructured":"Poggiolini I, Gupta V, Lawton M, Lee S, El-Turabi A, Querejeta-Coma A, Trenkwalder C, Sixel-D\u00f6ring F, Foubert-Samier A, Pavy-Le Traon A, Plazzi G, Biscarini F, Montplaisir J, Gagnon JF, Postuma RB, Antelmi E, Meissner WG, Mollenhauer B, Ben-Shlomo Y, Hu MT, Parkkinen L (2022) Diagnostic value of cerebrospinal fluid alpha-synuclein seed quantification in synucleinopathies. Brain 145(2):584\u2013595. https:\/\/doi.org\/10.1093\/brain\/awab431","journal-title":"Brain"},{"issue":"1","key":"2930_CR76","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/s41531-021-00232-4","volume":"7","author":"C Quadalti","year":"2021","unstructured":"Quadalti C, Calandra-Buonaura G, Baiardi S, Mastrangelo A, Rossi M, Zenesini C, Giannini G, Candelise N, Sambati L, Polischi B, Plazzi G, Capellari S, Cortelli P, Parchi P (2021) Neurofilament light chain and \u03b1-synuclein RT-QuIC as differential diagnostic biomarkers in parkinsonisms and related syndromes. NPJ Parkinson\u2019s Dis 7(1):93. https:\/\/doi.org\/10.1038\/s41531-021-00232-4","journal-title":"NPJ Parkinson's Dis"},{"issue":"7","key":"2930_CR77","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1002\/mds.27034","volume":"32","author":"G Respondek","year":"2017","unstructured":"Respondek G, Kurz C, Arzberger T, Compta Y, Englund E, Ferguson LW, Gelpi E, Giese A, Irwin DJ, Meissner WG, Nilsson C, Pantelyat A, Rajput A, van Swieten JC, Troakes C, Josephs KA, Lang AE, Mollenhauer B, M\u00fcller U, Whitwell JL, Antonini A, Bhatia KP, Bordelon Y, Corvol JC, Colosimo C, Dodel R, Grossman M, Kassubek J, Krismer F, Levin J, Lorenzl S, Morris H, Nestor P, Oertel WH, Rabinovici GD, Rowe JB, van Eimeren T, Wenning GK, Boxer A, Golbe LI, Litvan I, Stamelou M, H\u00f6glinger GU (2017) Which ante mortem clinical features predict progressive supranuclear palsy pathology? Mov Disord 32(7):995\u20131005. https:\/\/doi.org\/10.1002\/mds.27034","journal-title":"Mov Disord"},{"key":"2930_CR78","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/bs.irn.2019.10.003","volume":"149","author":"G Respondek","year":"2019","unstructured":"Respondek G, Stamelou M, H\u00f6glinger GU (2019) Classification of atypical Parkinsonism per pathology versus phenotype. Int Rev Neurobiol 149:37\u201347. https:\/\/doi.org\/10.1016\/bs.irn.2019.10.003","journal-title":"Int Rev Neurobiol"},{"issue":"7","key":"2930_CR79","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1093\/brain\/awy146","volume":"141","author":"JL Robinson","year":"2018","unstructured":"Robinson JL, Lee EB, Xie SX, Rennert L, Suh E, Bredenberg C, Caswell C, Van Deerlin VM, Yan N, Yousef A, Hurtig HI, Siderowf A, Grossman M, McMillan CT, Miller B, Duda JE, Irwin DJ, Wolk D, Elman L, McCluskey L, Chen-Plotkin A, Weintraub D, Arnold SE, Brettschneider J, Lee VM, Trojanowski JQ (2018) Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associated. Brain 141(7):2181\u20132193. https:\/\/doi.org\/10.1093\/brain\/awy146","journal-title":"Brain"},{"issue":"1","key":"2930_CR80","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s00401-020-02160-8","volume":"140","author":"M Rossi","year":"2020","unstructured":"Rossi M, Candelise N, Baiardi S, Capellari S, Giannini G, Orr\u00f9 CD, Antelmi E, Mammana A, Hughson AG, Calandra-Buonaura G, Ladogana A, Plazzi G, Cortelli P, Caughey B, Parchi P (2020) Ultrasensitive RT-QuIC assay with high sensitivity and specificity for Lewy body-associated synucleinopathies. Acta Neuropathol 140(1):49\u201362. https:\/\/doi.org\/10.1007\/s00401-020-02160-8","journal-title":"Acta Neuropathol"},{"key":"2930_CR81","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.parkreldis.2020.06.004","volume":"76","author":"A Santaella","year":"2020","unstructured":"Santaella A, Kuiperij HB, van Rumund A, Esselink RAJ, Bloem BR, Verbeek MM (2020) Cerebrospinal fluid myelin basic protein is elevated in multiple system atrophy. Parkinsonism Relat Disord 76:80\u201384. https:\/\/doi.org\/10.1016\/j.parkreldis.2020.06.004","journal-title":"Parkinsonism Relat Disord"},{"issue":"9","key":"2930_CR82","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1007\/s00702-018-1893-1","volume":"125","author":"T Schirinzi","year":"2018","unstructured":"Schirinzi T, Sancesario GM, Di Lazzaro G, Scalise S, Colona VL, Imbriani P, Mercuri NB, Bernardini S, Lang AE, Pisani A (2018) Clinical value of CSF amyloid-beta-42 and tau proteins in progressive supranuclear palsy. J Neural Trans. 125(9):1373\u20131379. https:\/\/doi.org\/10.1007\/s00702-018-1893-1","journal-title":"J Neural Trans."},{"issue":"1","key":"2930_CR83","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1212\/WNL.0b013e31823ed0f0","volume":"78","author":"NS Schoonenboom","year":"2012","unstructured":"Schoonenboom NS, Reesink FE, Verwey NA, Kester MI, Teunissen CE, van de Ven PM, Pijnenburg YA, Blankenstein MA, Rozemuller AJ, Scheltens P, van der Flier WM (2012) Cerebrospinal fluid markers for differential dementia diagnosis in a large memory clinic cohort. Neurology 78(1):47\u201354. https:\/\/doi.org\/10.1212\/WNL.0b013e31823ed0f0","journal-title":"Neurology"},{"issue":"12","key":"2930_CR84","doi-asserted-by":"publisher","first-page":"2874","DOI":"10.1002\/mds.28738","volume":"36","author":"I Schulz","year":"2021","unstructured":"Schulz I, Kruse N, Gera RG, Kremer T, Cedarbaum J, Barbour R, Zago W, Schade S, Otte B, Bartl M, Hutten SJ, Trenkwalder C, Mollenhauer B (2021) Systematic assessment of 10 biomarker candidates focusing on \u03b1-synuclein-related disorders. Mov Disord. 36(12):2874\u20132887. https:\/\/doi.org\/10.1002\/mds.28738","journal-title":"Mov Disord."},{"issue":"1","key":"2930_CR85","doi-asserted-by":"publisher","first-page":"395","DOI":"10.3233\/jad-181152","volume":"68","author":"Y Seino","year":"2019","unstructured":"Seino Y, Nakamura T, Kawarabayashi T, Hirohata M, Narita S, Wakasaya Y, Kaito K, Ueda T, Harigaya Y, Shoji M (2019) Cerebrospinal fluid and plasma biomarkers in neurodegenerative diseases. J Alzheimer\u2019s Dis 68(1):395\u2013404. https:\/\/doi.org\/10.3233\/jad-181152","journal-title":"J Alzheimer's Dis"},{"issue":"7794","key":"2930_CR86","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/s41586-020-1984-7","volume":"578","author":"M Shahnawaz","year":"2020","unstructured":"Shahnawaz M, Mukherjee A, Pritzkow S, Mendez N, Rabadia P, Liu X, Hu B, Schmeichel A, Singer W, Wu G, Tsai AL, Shirani H, Nilsson KPR, Low PA, Soto C (2020) Discriminating \u03b1-synuclein strains in Parkinson\u2019s disease and multiple system atrophy. Nature 578(7794):273\u2013277. https:\/\/doi.org\/10.1038\/s41586-020-1984-7","journal-title":"Nature"},{"issue":"3","key":"2930_CR87","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1002\/ana.22311","volume":"69","author":"M Shi","year":"2011","unstructured":"Shi M, Bradner J, Hancock AM, Chung KA, Quinn JF, Peskind ER, Galasko D, Jankovic J, Zabetian CP, Kim HM, Leverenz JB, Montine TJ, Ginghina C, Kang UJ, Cain KC, Wang Y, Aasly J, Goldstein D, Zhang J (2011) Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression. Ann Neurol 69(3):570\u2013580. https:\/\/doi.org\/10.1002\/ana.22311","journal-title":"Ann Neurol"},{"issue":"3","key":"2930_CR88","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.jalz.2016.09.008","volume":"13","author":"AH Simonsen","year":"2017","unstructured":"Simonsen AH, Herukka SK, Andreasen N, Baldeiras I, Bjerke M, Blennow K, Engelborghs S, Frisoni GB, Gabryelewicz T, Galluzzi S, Handels R, Kramberger MG, Kulczy\u0144ska A, Molinuevo JL, Mroczko B, Nordberg A, Oliveira CR, Otto M, Rinne JO, Rot U, Saka E, Soininen H, Struyfs H, Suardi S, Visser PJ, Winblad B, Zetterberg H, Waldemar G (2017) Recommendations for CSF AD biomarkers in the diagnostic evaluation of dementia. Alzheimer\u2019s Dement 13(3):274\u2013284. https:\/\/doi.org\/10.1016\/j.jalz.2016.09.008","journal-title":"Alzheimer's Dement"},{"issue":"2","key":"2930_CR89","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/s1474-4422(23)00405-2","volume":"23","author":"T Simuni","year":"2024","unstructured":"Simuni T, Chahine LM, Poston K, Brumm M, Buracchio T, Campbell M, Chowdhury S, Coffey C, Concha-Marambio L, Dam T, DiBiaso P, Foroud T, Frasier M, Gochanour C, Jennings D, Kieburtz K, Kopil CM, Merchant K, Mollenhauer B, Montine T, Nudelman K, Pagano G, Seibyl J, Sherer T, Singleton A, Stephenson D, Stern M, Soto C, Tanner CM, Tolosa E, Weintraub D, Xiao Y, Siderowf A, Dunn B, Marek K (2024) A biological definition of neuronal \u03b1-synuclein disease: towards an integrated staging system for research. Lancet Neurol 23(2):178\u2013190. https:\/\/doi.org\/10.1016\/s1474-4422(23)00405-2","journal-title":"Lancet Neurol"},{"issue":"12","key":"2930_CR90","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1212\/wnl.0000000000003737","volume":"88","author":"W Singer","year":"2017","unstructured":"Singer W, Berini SE, Sandroni P, Fealey RD, Coon EA, Suarez MD, Benarroch EE, Low PA (2017) Pure autonomic failure: predictors of conversion to clinical CNS involvement. Neurology 88(12):1129\u20131136. https:\/\/doi.org\/10.1212\/wnl.0000000000003737","journal-title":"Neurology"},{"issue":"3","key":"2930_CR91","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1002\/ana.25824","volume":"88","author":"W Singer","year":"2020","unstructured":"Singer W, Schmeichel AM, Shahnawaz M, Schmelzer JD, Boeve BF, Sletten DM, Gehrking TL, Gehrking JA, Olson AD, Savica R, Suarez MD, Soto C, Low PA (2020) Alpha-synuclein oligomers and neurofilament light chain in spinal fluid differentiate multiple system atrophy from Lewy body synucleinopathies. Ann Neurol 88(3):503\u2013512. https:\/\/doi.org\/10.1002\/ana.25824","journal-title":"Ann Neurol"},{"key":"2930_CR92","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3389\/fnmol.2019.00129","volume":"12","author":"AP Singh","year":"2019","unstructured":"Singh AP, Ramana G, Bajaj T, Singh V, Dwivedi S, Behari M, Dey AB, Dey S (2019) Elevated serum SIRT 2 may differentiate Parkinson\u2019s disease from atypical Parkinsonian syndromes. Front Mol Neurosci 12:129. https:\/\/doi.org\/10.3389\/fnmol.2019.00129","journal-title":"Front Mol Neurosci"},{"issue":"20","key":"2930_CR93","doi-asserted-by":"publisher","first-page":"4016","DOI":"10.1093\/hmg\/ddr330","volume":"20","author":"PY Smith","year":"2011","unstructured":"Smith PY, Delay C, Girard J, Papon MA, Planel E, Sergeant N, Bu\u00e9e L, H\u00e9bert SS (2011) MicroRNA-132 loss is associated with tau exon 10 inclusion in progressive supranuclear palsy. Hum Mol Genet 20(20):4016\u20134024. https:\/\/doi.org\/10.1093\/hmg\/ddr330","journal-title":"Hum Mol Genet"},{"issue":"2","key":"2930_CR94","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3233\/jad-2009-0955","volume":"16","author":"PE Spies","year":"2009","unstructured":"Spies PE, Melis RJ, Sj\u00f6gren MJ, Rikkert MG, Verbeek MM (2009) Cerebrospinal fluid alpha-synuclein does not discriminate between dementia disorders. J Alzheimer\u2019s Dis 16(2):363\u2013369. https:\/\/doi.org\/10.3233\/jad-2009-0955","journal-title":"J Alzheimer's Dis"},{"issue":"1","key":"2930_CR95","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1186\/s12974-018-1339-6","volume":"15","author":"C Starhof","year":"2018","unstructured":"Starhof C, Winge K, Heegaard NHH, Skogstrand K, Friis S, Hejl A (2018) Cerebrospinal fluid pro-inflammatory cytokines differentiate parkinsonian syndromes. J Neuroinflammation 15(1):305. https:\/\/doi.org\/10.1186\/s12974-018-1339-6","journal-title":"J Neuroinflammation"},{"key":"2930_CR02","doi-asserted-by":"crossref","unstructured":"Stuendl A, Kraus T, Chatterjee M, Zapke B, Sadowski B, Moebius W, Hobert MA, Deuschle C, Brockmann K, Maetzler W, Mollenhauer B, Schneider A. \u03b1-Synuclein in Plasma-Derived Extracellular Vesicles Is a Potential Biomarker of Parkinson's Disease. Mov Disord. 2021;36(11):2508\u201318.","DOI":"10.1002\/mds.28639"},{"issue":"3","key":"2930_CR96","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1002\/mds.25688","volume":"29","author":"ZF Sun","year":"2014","unstructured":"Sun ZF, Xiang XS, Chen Z, Zhang L, Tang BS, Xia K, Jiang H (2014) Increase of the plasma \u03b1-synuclein levels in patients with multiple system atrophy. Mov Disord 29(3):375\u2013379. https:\/\/doi.org\/10.1002\/mds.25688","journal-title":"Mov Disord"},{"issue":"9","key":"2930_CR97","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1002\/mds.22895","volume":"25","author":"SD S\u00fcssmuth","year":"2010","unstructured":"S\u00fcssmuth SD, Uttner I, Landwehrmeyer B, Pinkhardt EH, Brettschneider J, Petzold A, Kramer B, Schulz JB, Palm C, Otto M, Ludolph AC, Kassubek J, Tumani H (2010) Differential pattern of brain-specific CSF proteins tau and amyloid-\u03b2 in Parkinsonian syndromes. Mov Disord 25(9):1284\u20131288. https:\/\/doi.org\/10.1002\/mds.22895","journal-title":"Mov Disord"},{"issue":"4","key":"2930_CR98","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1097\/wco.0000000000000707","volume":"32","author":"P Svenningsson","year":"2019","unstructured":"Svenningsson P (2019) Corticobasal degeneration: advances in clinicopathology and biomarkers. Curr Opin Neurol 32(4):597\u2013603. https:\/\/doi.org\/10.1097\/wco.0000000000000707","journal-title":"Curr Opin Neurol"},{"issue":"4","key":"2930_CR99","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1007\/s00415-023-12093-3","volume":"271","author":"HB Taha","year":"2024","unstructured":"Taha HB, Bogoniewski A (2024) Analysis of biomarkers in speculative CNS-enriched extracellular vesicles for parkinsonian disorders: a comprehensive systematic review and diagnostic meta-analysis. J Neurol 271(4):1680\u20131706. https:\/\/doi.org\/10.1007\/s00415-023-12093-3","journal-title":"J Neurol"},{"issue":"3","key":"2930_CR100","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1097\/WAD.0b013e31823899cc","volume":"26","author":"F Tateno","year":"2012","unstructured":"Tateno F, Sakakibara R, Kawai T, Kishi M, Murano T (2012) Alpha-synuclein in the cerebrospinal fluid differentiates synucleinopathies (Parkinson disease, dementia with Lewy bodies, multiple system atrophy) from Alzheimer disease. Alzheimer Dis Assoc Disord 26(3):213\u2013216. https:\/\/doi.org\/10.1097\/WAD.0b013e31823899cc","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"3","key":"2930_CR101","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s10048-016-0480-6","volume":"17","author":"R Tatura","year":"2016","unstructured":"Tatura R, Buchholz M, Dickson DW, van Swieten J, McLean C, H\u00f6glinger G, M\u00fcller U (2016) microRNA profiling: increased expression of miR-147a and miR-518e in progressive supranuclear palsy (PSP). Neurogenetics 17(3):165\u2013171. https:\/\/doi.org\/10.1007\/s10048-016-0480-6","journal-title":"Neurogenetics"},{"issue":"20","key":"2930_CR102","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1212\/WNL.0b013e3181fd613b","volume":"75","author":"T Tokuda","year":"2010","unstructured":"Tokuda T, Qureshi MM, Ardah MT, Varghese S, Shehab SA, Kasai T, Ishigami N, Tamaoka A, Nakagawa M, El-Agnaf OM (2010) Detection of elevated levels of \u03b1-synuclein oligomers in CSF from patients with Parkinson disease. Neurology 75(20):1766\u20131772. https:\/\/doi.org\/10.1212\/WNL.0b013e3181fd613b","journal-title":"Neurology"},{"issue":"6","key":"2930_CR103","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1111\/ejn.12444","volume":"39","author":"K Ubhi","year":"2014","unstructured":"Ubhi K, Rockenstein E, Kragh C, Inglis C, Spencer B, Michael S, Mante M, Adame A, Galasko D, Masliah E (2014) Widespread microRNA dysregulation in multiple system atrophy\u2014disease-related alteration in miR-96. Eur J Neurosci 39(6):1026\u20131041. https:\/\/doi.org\/10.1111\/ejn.12444","journal-title":"Eur J Neurosci"},{"issue":"1","key":"2930_CR104","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/s0022-510x(00)00480-9","volume":"183","author":"K Urakami","year":"2001","unstructured":"Urakami K, Wada K, Arai H, Sasaki H, Kanai M, Shoji M, Ishizu H, Kashihara K, Yamamoto M, Tsuchiya-Ikemoto K, Morimatsu M, Takashima H, Nakagawa M, Kurokawa K, Maruyama H, Kaseda Y, Nakamura S, Hasegawa K, Oono H, Hikasa C, Ikeda K, Yamagata K, Wakutani Y, Takeshima T, Nakashima K (2001) Diagnostic significance of tau protein in cerebrospinal fluid from patients with corticobasal degeneration or progressive supranuclear palsy. J Neurol Sci 183(1):95\u201398. https:\/\/doi.org\/10.1016\/s0022-510x(00)00480-9","journal-title":"J Neurol Sci"},{"issue":"1","key":"2930_CR105","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13041-019-0471-2","volume":"12","author":"H Uwatoko","year":"2019","unstructured":"Uwatoko H, Hama Y, Iwata IT, Shirai S, Matsushima M, Yabe I, Utsumi J, Sasaki H (2019) Identification of plasma microRNA expression changes in multiple system atrophy and Parkinson\u2019s disease. Mol Brain 12(1):49. https:\/\/doi.org\/10.1186\/s13041-019-0471-2","journal-title":"Mol Brain"},{"key":"2930_CR106","doi-asserted-by":"publisher","first-page":"329","DOI":"10.3389\/fnmol.2017.00329","volume":"10","author":"E Valera","year":"2017","unstructured":"Valera E, Spencer B, Mott J, Trejo M, Adame A, Mante M, Rockenstein E, Troncoso JC, Beach TG, Masliah E, Desplats P (2017) MicroRNA-101 modulates autophagy and oligodendroglial alpha-synuclein accumulation in multiple system atrophy. Front Mol Neurosci 10:329. https:\/\/doi.org\/10.3389\/fnmol.2017.00329","journal-title":"Front Mol Neurosci"},{"key":"2930_CR107","doi-asserted-by":"publisher","first-page":"156","DOI":"10.3389\/fncel.2014.00156","volume":"8","author":"A Vallelunga","year":"2014","unstructured":"Vallelunga A, Ragusa M, Di Mauro S, Iannitti T, Pilleri M, Biundo R, Weis L, Di Pietro C, De Iuliis A, Nicoletti A, Zappia M, Purrello M, Antonini A (2014) Identification of circulating microRNAs for the differential diagnosis of Parkinson\u2019s disease and multiple system atrophy. Front Cell Neurosci 8:156. https:\/\/doi.org\/10.3389\/fncel.2014.00156","journal-title":"Front Cell Neurosci"},{"key":"2930_CR108","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2021.632891","volume":"13","author":"A Vallelunga","year":"2021","unstructured":"Vallelunga A, Iannitti T, Capece S, Somma G, Russillo MC, Foubert-Samier A, Laurens B, Sibon I, Meissner WG, Barone P, Pellecchia MT (2021) Serum miR-96-5P and miR-339-5P are potential biomarkers for multiple system atrophy and Parkinson\u2019s disease. Front Aging Neurosci 13:632891. https:\/\/doi.org\/10.3389\/fnagi.2021.632891","journal-title":"Front Aging Neurosci"},{"issue":"5","key":"2930_CR109","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1002\/ana.25447","volume":"85","author":"A van Rumund","year":"2019","unstructured":"van Rumund A, Green AJE, Fairfoul G, Esselink RAJ, Bloem BR, Verbeek MM (2019) \u03b1-Synuclein real-time quaking-induced conversion in the cerebrospinal fluid of uncertain cases of parkinsonism. Ann Neurol 85(5):777\u2013781. https:\/\/doi.org\/10.1002\/ana.25447","journal-title":"Ann Neurol"},{"issue":"12","key":"2930_CR110","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1002\/mds.30019","volume":"39","author":"DP Vaughan","year":"2024","unstructured":"Vaughan DP, Fumi R, Theilmann Jensen M, Hodgson M, Georgiades T, Wu L, Lux D, Obrocki R, Lamoureux J, Ansorge O, Allinson KSJ, Warner TT, Jaunmuktane Z, Misbahuddin A, Leigh PN, Ghosh BCP, Bhatia KP, Church A, Kobylecki C, Hu MTM, Rowe JB, Blauwendraat C, Morris HR (2024) Evaluation of cerebrospinal fluid \u03b1-synuclein seed amplification assay in progressive supranuclear palsy and corticobasal syndrome. Mov Disord 39(12):2285\u20132291. https:\/\/doi.org\/10.1002\/mds.30019","journal-title":"Mov Disord"},{"issue":"3","key":"2930_CR111","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1136\/jnnp-2014-308004","volume":"86","author":"D Wagshal","year":"2015","unstructured":"Wagshal D, Sankaranarayanan S, Guss V, Hall T, Berisha F, Lobach I, Karydas A, Voltarelli L, Scherling C, Heuer H, Tartaglia MC, Miller Z, Coppola G, Ahlijanian M, Soares H, Kramer JH, Rabinovici GD, Rosen HJ, Miller BL, Meredith J, Boxer AL (2015) Divergent CSF \u03c4 alterations in two common tauopathies: Alzheimer\u2019s disease and progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 86(3):244\u2013250. https:\/\/doi.org\/10.1136\/jnnp-2014-308004","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"121","key":"2930_CR112","doi-asserted-by":"publisher","first-page":"121120","DOI":"10.1126\/scitranslmed.3002566","volume":"4","author":"Y Wang","year":"2012","unstructured":"Wang Y, Shi M, Chung KA, Zabetian CP, Leverenz JB, Berg D, Srulijes K, Trojanowski JQ, Lee VM, Siderowf AD, Hurtig H, Litvan I, Schiess MC, Peskind ER, Masuda M, Hasegawa M, Lin X, Pan C, Galasko D, Goldstein DS, Jensen PH, Yang H, Cain KC, Zhang J (2012) Phosphorylated \u03b1-synuclein in Parkinson\u2019s disease. Sci Transl Med 4(121):121120. https:\/\/doi.org\/10.1126\/scitranslmed.3002566","journal-title":"Sci Transl Med"},{"key":"2930_CR113","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.neulet.2015.05.030","volume":"599","author":"X Wang","year":"2015","unstructured":"Wang X, Yu S, Li F, Feng T (2015) Detection of \u03b1-synuclein oligomers in red blood cells as a potential biomarker of Parkinson\u2019s disease. Neurosci Lett 599:115\u2013119. https:\/\/doi.org\/10.1016\/j.neulet.2015.05.030","journal-title":"Neurosci Lett"},{"issue":"4","key":"2930_CR114","doi-asserted-by":"publisher","first-page":"488","DOI":"10.3988\/jcn.2019.15.4.488","volume":"15","author":"HL Wang","year":"2019","unstructured":"Wang HL, Lu CS, Yeh TH, Shen YM, Weng YH, Huang YZ, Chen RS, Liu YC, Cheng YC, Chang HC, Chen YL, Chen YJ, Lin YW, Hsu CC, Lin HL, Chiu CH, Chiu CC (2019) Combined assessment of serum alpha-synuclein and Rab35 is a better biomarker for Parkinson\u2019s disease. J Clin Neurol 15(4):488\u2013495. https:\/\/doi.org\/10.3988\/jcn.2019.15.4.488","journal-title":"J Clin Neurol"},{"issue":"6","key":"2930_CR115","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1002\/mds.29005","volume":"37","author":"GK Wenning","year":"2022","unstructured":"Wenning GK, Stankovic I, Vignatelli L, Fanciulli A, Calandra-Buonaura G, Seppi K, Palma JA, Meissner WG, Krismer F, Berg D, Cortelli P, Freeman R, Halliday G, H\u00f6glinger G, Lang A, Ling H, Litvan I, Low P, Miki Y, Panicker J, Pellecchia MT, Quinn N, Sakakibara R, Stamelou M, Tolosa E, Tsuji S, Warner T, Poewe W, Kaufmann H (2022) The movement disorder society criteria for the diagnosis of multiple system atrophy. Mov Disord 37(6):1131\u20131148. https:\/\/doi.org\/10.1002\/mds.29005","journal-title":"Mov Disord"},{"key":"2930_CR01","doi-asserted-by":"crossref","unstructured":"Wennstr\u00f6m M, Surova Y, Hall S, Nilsson C, Minthon L, Bostr\u00f6m F, Hansson O, Nielsen HM. Low CSF levels of both \u03b1-synuclein and the \u03b1-synuclein cleaving enzyme neurosin in patients with synucleinopathy. PLoS One. 2013;8(1):e53250.","DOI":"10.1371\/journal.pone.0053250"},{"issue":"8","key":"2930_CR116","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0135458","volume":"10","author":"M Wennstr\u00f6m","year":"2015","unstructured":"Wennstr\u00f6m M, Surova Y, Hall S, Nilsson C, Minthon L, Hansson O, Nielsen HM (2015) The inflammatory marker YKL-40 is elevated in cerebrospinal fluid from patients with Alzheimer\u2019s but not Parkinson\u2019s disease or dementia with Lewy bodies. PLoS ONE 10(8):e0135458. https:\/\/doi.org\/10.1371\/journal.pone.0135458","journal-title":"PLoS ONE"},{"issue":"3","key":"2930_CR117","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1074\/jbc.RA118.004471","volume":"294","author":"TR Yamasaki","year":"2019","unstructured":"Yamasaki TR, Holmes BB, Furman JL, Dhavale DD, Su BW, Song ES, Cairns NJ, Kotzbauer PT, Diamond MI (2019) Parkinson\u2019s disease and multiple system atrophy have distinct \u03b1-synuclein seed characteristics. J Biol Chem 294(3):1045\u20131058. https:\/\/doi.org\/10.1074\/jbc.RA118.004471","journal-title":"J Biol Chem"},{"key":"2930_CR118","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2022.136868","volume":"789","author":"X Zhang","year":"2022","unstructured":"Zhang X, Wang S, Li X, Li X, Ran W, Liu C, Tian W, Yu X, Wu C, Li P, Li N, Wei Y, Wang Y, Yu S, Chen Z (2022) Hemoglobin-binding \u03b1-synuclein levels in erythrocytes are elevated in patients with multiple system atrophy. Neurosci Lett 789:136868. https:\/\/doi.org\/10.1016\/j.neulet.2022.136868","journal-title":"Neurosci Lett"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-025-02930-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00702-025-02930-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-025-02930-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T15:07:32Z","timestamp":1751296052000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00702-025-02930-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,20]]},"references-count":121,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["2930"],"URL":"https:\/\/doi.org\/10.1007\/s00702-025-02930-2","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,20]]},"assertion":[{"value":"17 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that there are no conflicts of interest relevant to this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The authors confirm that neither the approval of an institutional review board nor patient consent was required for this work. We confirm that we have read the Journal\u2019s position on issues involved in ethical publication and affirm that this work is consistent with those guidelines.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}